Literature DB >> 28123013

Loss of Plasticity in the D2-Accumbens Pallidal Pathway Promotes Cocaine Seeking.

Jasper A Heinsbroek1, Daniela N Neuhofer2, William C Griffin3, Griffin S Siegel3, Ana-Clara Bobadilla2, Yonatan M Kupchik4, Peter W Kalivas1,3.   

Abstract

Distinct populations of D1- and D2-dopamine receptor-expressing medium spiny neurons (D1-/D2-MSNs) comprise the nucleus accumbens, and activity in D1-MSNs promotes, whereas activity in D2-MSNs inhibits, motivated behaviors. We used chemogenetics to extend D1-/D2-MSN cell specific regulation to cue-reinstated cocaine seeking in a mouse model of self-administration and relapse, and found that either increasing activity in D1-MSNs or decreasing activity in D2-MSNs augmented cue-induced reinstatement. Both D1- and D2-MSNs provide substantial GABAergic innervation to the ventral pallidum, and chemogenetic inhibition of ventral pallidal neurons blocked the augmented reinstatement elicited by chemogenetic regulation of either D1- or D2-MSNs. Because D1- and D2-MSNs innervate overlapping populations of ventral pallidal neurons, we next used optogenetics to examine whether changes in synaptic plasticity in D1- versus D2-MSN GABAergic synapses in the ventral pallidum could explain the differential regulation of VP activity. In mice trained to self-administer cocaine, GABAergic LTD was abolished in D2-, but not in D1-MSN synapses. A μ opioid receptor antagonist restored GABA currents in D2-, but not D1-MSN synapses of cocaine-trained mice, indicating that increased enkephalin tone on presynaptic μ opioid receptors was responsible for occluding the LTD. These results identify a behavioral function for D1-MSN innervation of the ventral pallidum, and suggest that losing LTDGABA in D2-MSN, but not D1-MSN input to ventral pallidum may promote cue-induced reinstatement of cocaine-seeking. SIGNIFICANCE STATEMENT: More than 90% of ventral striatum is composed of two cell types, those expressing dopamine D1 or D2 receptors, which exert opposing roles on motivated behavior. Both cell types send GABAergic projections to the ventral pallidum and were found to differentially promote cue-induced reinstatement of cocaine seeking via the ventral pallidum. Furthermore, after cocaine self-administration, synaptic plasticity was selectively lost in D2, but not D1 inputs to the ventral pallidum. The selective impairment in D2 afferents may promote the influence of D1 inputs to drive relapse to cocaine seeking.
Copyright © 2017 the authors 0270-6474/17/370757-11$15.00/0.

Entities:  

Keywords:  GABA; LTD; accumbens; cocaine; pallidum; relapse

Mesh:

Substances:

Year:  2017        PMID: 28123013      PMCID: PMC5296778          DOI: 10.1523/JNEUROSCI.2659-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

1.  Acquisition of lever pressing for cocaine in C57BL/6J mice: effects of prior Pavlovian conditioning.

Authors:  W C Griffin; L D Middaugh
Journal:  Pharmacol Biochem Behav       Date:  2003-12       Impact factor: 3.533

2.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand.

Authors:  Blaine N Armbruster; Xiang Li; Mark H Pausch; Stefan Herlitze; Bryan L Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

3.  Contrasting forms of cocaine-evoked plasticity control components of relapse.

Authors:  Vincent Pascoli; Jean Terrier; Julie Espallergues; Emmanuel Valjent; Eoin Cornelius O'Connor; Christian Lüscher
Journal:  Nature       Date:  2014-05-22       Impact factor: 49.962

4.  Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens.

Authors:  X Y Lu; M B Ghasemzadeh; P W Kalivas
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

5.  Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway.

Authors:  S N Haber; H J Groenewegen; E A Grove; W J Nauta
Journal:  J Comp Neurol       Date:  1985-05-15       Impact factor: 3.215

Review 6.  D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.

Authors:  D James Surmeier; Jun Ding; Michelle Day; Zhongfeng Wang; Weixing Shen
Journal:  Trends Neurosci       Date:  2007-04-03       Impact factor: 13.837

Review 7.  Modulation of striatal projection systems by dopamine.

Authors:  Charles R Gerfen; D James Surmeier
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

8.  Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways).

Authors:  Rachel J Smith; Mary Kay Lobo; Sade Spencer; Peter W Kalivas
Journal:  Curr Opin Neurobiol       Date:  2013-02-18       Impact factor: 6.627

Review 9.  Self-administration of drugs in animals and humans as a model and an investigative tool.

Authors:  Leigh V Panlilio; Steven R Goldberg
Journal:  Addiction       Date:  2007-12       Impact factor: 6.526

10.  Evidence for the coexistence of glutamate decarboxylase and Met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum.

Authors:  D S Zahm; L Zaborszky; V E Alones; L Heimer
Journal:  Brain Res       Date:  1985-01-28       Impact factor: 3.252

View more
  58 in total

Review 1.  The ventral pallidum and relapse in alcohol seeking.

Authors:  Asheeta A Prasad; Gavan P McNally
Journal:  Br J Pharmacol       Date:  2020-07-09       Impact factor: 8.739

2.  Ventral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking.

Authors:  Thibaut R Pardo-Garcia; Constanza Garcia-Keller; Tiffany Penaloza; Christopher T Richie; James Pickel; Bruce T Hope; Brandon K Harvey; Peter W Kalivas; Jasper A Heinsbroek
Journal:  J Neurosci       Date:  2019-01-08       Impact factor: 6.167

3.  Paradoxical accentuation of motivation following accumbens-pallidum disconnection.

Authors:  Stephen E Chang; Travis P Todd; Kyle S Smith
Journal:  Neurobiol Learn Mem       Date:  2018-02-03       Impact factor: 2.877

4.  HDAC5 and Its Target Gene, Npas4, Function in the Nucleus Accumbens to Regulate Cocaine-Conditioned Behaviors.

Authors:  Makoto Taniguchi; Maria B Carreira; Yonatan A Cooper; Ana-Clara Bobadilla; Jasper A Heinsbroek; Nobuya Koike; Erin B Larson; Evan A Balmuth; Brandon W Hughes; Rachel D Penrod; Jaswinder Kumar; Laura N Smith; Daniel Guzman; Joseph S Takahashi; Tae-Kyung Kim; Peter W Kalivas; David W Self; Yingxi Lin; Christopher W Cowan
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

Review 5.  Reward Circuitry in Addiction.

Authors:  Sarah Cooper; A J Robison; Michelle S Mazei-Robison
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

6.  Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc.

Authors:  Stephan Steidl; Shannon O'Sullivan; Dustin Pilat; Nancy Bubula; Jason Brown; Paul Vezina
Journal:  Behav Brain Res       Date:  2017-06-27       Impact factor: 3.332

Review 7.  Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction.

Authors:  Daniela Neuhofer; Peter Kalivas
Journal:  Neurobiol Learn Mem       Date:  2018-02-09       Impact factor: 2.877

Review 8.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

Review 9.  Inhibitory Plasticity of Mesocorticolimbic Circuits in Addiction and Mental Illness.

Authors:  Alexey Ostroumov; John A Dani
Journal:  Trends Neurosci       Date:  2018-08-24       Impact factor: 13.837

10.  Metaplasticity in the Ventral Pallidum as a Potential Marker for the Propensity to Gain Weight in Chronic High-Calorie Diet.

Authors:  Shani Gendelis; Dorrit Inbar; Kineret Inbar; Shanee Mesner; Yonatan M Kupchik
Journal:  J Neurosci       Date:  2020-11-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.